33 Blood-based tumor mutation burden (bTMB) predicts response to immune checkpoint blockade-based combination therapy (ICBC) in advanced non-small cell lung cancer (NSCLC): a real-... by Nicole Zhang, Leylah Drusbosky, Jiemin Liao, Bruna Pellini, Sean Gordon, Reagan Barnett, Katie Quinn, Sara Wienke, Martina Lefterova, Lauren Lawrence, Lesli Kiedrowski, Ross Eppler, Justin Odegaard, Han-Yu Chuang